Abcuro
Kristin Lurk, PMP, currently serves as Senior Director of Program Management at Abcuro, Inc., following a tenure as Senior Director of Program and Project Management at Talaris Therapeutics. At Talaris, Kristin led program management across multiple clinical-stage programs, established a refined PMO structure, created a Program Management Playbook, and initiated regular program review processes. Previous roles include Global Clinical Project Manager at Covance, Clinical Project Manager at CTI Clinical Trial and Consulting Services, and Clinical Research Coordinator at Washington University School of Medicine. Kristin's extensive background also includes 14 years at Boeing in various project management and operational excellence roles, along with an analytical position at Anheuser-Busch. Education includes a Graduate Certificate in Clinical Trials Management from the University of Chicago and dual master's and bachelor's degrees in Engineering Management from Missouri University of Science and Technology.
This person is not in the org chart
This person is not in any offices
Abcuro
2 followers
Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class anti-KLRG1 antibody designed to deplete cytotoxic T cells that attack healthy muscle tissue in patients with inclusion body myositis (IBM), into clinical studies.